Please see below for a list of search results.
Please note that if you are not undertaking activities relating to material for human application, for example you carry out organ donation and transplantation, post mortems or anatomical examinations, this system is not applicable to you.
According to the 2013 House of Lords report on Regenerative Medicine, the term ‘regenerative medicine’ refers to methods to replace or regenerate human cells, tissues or organs in order to restore or establish normal function.
The Human Fertilisation and Embryology Authority (HFEA) and the Human Tissue Authority (HTA) have been working together to reduce the regulatory overlap regarding the storage of ovarian and testicular tissue.
All establishments in the Human Application sector must follow the HTA’s Guide to Quality and Safety Assurance for Tissue and Cells for Patient Treatment.
This guide explains the requirements for:
The list provides guidance to the human application sector on which types of tissues and cells are regulated under the Human Tissue (Quality and Safety for Human Application) Regulations 2007 (as amended).
Licensed establishments are required to meet the standards that are detailed in the HTA’s assessment criteria.
The Department of Health and Social Care has published guidance for industry and organisations involved in health and care about plans for a no-deal Brexit.
This guide explains the requirements for licences which store tissues and cells for human application and for licences and/or third party agreements which carry out the procurement, testing, processing, distribution, import or export of tissues and cells for human application.